Clinical Trial Update: Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study [Phase 4]

View source ↗

Summary

A Phase 4 trial update assessing affordability and real-world effectiveness of antiplatelet treatment after myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Snippet

Sponsor: AstraZeneca | Conditions: Cost Sharing, Acute Coronary Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2019-10-01